Follow The Filings

RXRXRecursion Pharmaceuticals Inc.

Q4 2025 13F holders among managers we track Latest ownership dossier

Ticker
RXRX
Type
Equity
Class
COMMON STOCK
Total reported value (long equity)
Manager Report date Value Shares